5)A combined model incorporating female sex, cTnT levels, and LVEF demonstrated a sensitivity of 99 % for ruling out life-threatening arrhythmia in patients with suspected AM, potentially allowing for earlier discharge from rhythm monitoring. This evidence concerns the gene TNNT2 and cardiac arrhythmia.